We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Advanced Medical Fibers to Pave Way for Surgical Sutures, Wound Dressings and Textile Implants with Special Capabilities

By HospiMedica International staff writers
Posted on 26 Jun 2024

Directly targeting a wound or inflammation site with medication has significant benefits: it ensures the active ingredient is effective immediately, and it avoids side effects elsewhere in the body. More...

Traditional methods of local administration, such as ointments and injections, however, struggle to provide precise, sustained dosing. Researchers are now pioneering a solution using medical fibers that encapsulate a liquid core loaded with therapeutic agents. These innovative fibers are being developed into medical products like surgical sutures, wound dressings, and textile implants capable of delivering medications like painkillers, antibiotics, or insulin with exact dosing over extended periods. This also supports personalized medicine by allowing for patient-specific drug dosages.

The research team at Empa (St. Gallen, Switzerland) has focused on using polycaprolactone (PCL), a biocompatible and biodegradable polymer, for the fiber's sheath. This material successfully holds and gradually releases therapeutic substances. The researchers utilized a special pilot plant to produce PCL fibers featuring a continuous liquid core through melt spinning, achieving stable, flexible fibers that could be used industrially. The release mechanics of these fibers were initially tested using fluorescent markers before moving on to actual drugs.

The release rate of these drugs is influenced by the molecular size: small molecules like ibuprofen permeate through the fiber sheath, while larger molecules exit at the fiber ends. This release can be controlled by adjusting the sheath thickness and its crystalline structure. The production process varies depending on the drug's heat sensitivity; for heat-stable drugs, the active ingredients are directly integrated into the core of the fibers during the melt spinning, whereas for sensitive ones, a placeholder is initially used to fill the liquid core that is later replaced by the actual drug.

These liquid core fibers, ranging from 50 to 200 micrometers in diameter, can be woven into textiles or potentially inserted directly into the body to release drugs like insulin over time. Notably, these fibers can be refilled once depleted. The potential applications for these fibers are vast, ranging from delivering pain relief and anti-inflammatory medications to antibiotics and lifestyle drugs. The next phase of development will focus on enhancing surgical sutures with antimicrobial properties to prevent infections during operations by embedding antibiotics directly into the suture material.

Related Links:
Empa


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.